Giles Partington, Principal Statistician at Phastar, recently provided an article for Clinical Research News explaining the basis of Bayesian statistics and discussing the application of this approach, particularly within rare disease trials, along with the opportunities and challenges.
Read the full article here: https://www.clinicalresearchnewsonline.com/news/2024/04/26/bayesian-statistics-an-important-yet-underutilized-paradigm-in-rare-disease-and-small-population-drug-development